Immune response to SARS-CoV-2 vaccination among chronic myeloid leukaemia patients on tyrosine kinase inhibitors

Introduction: Chronic myeloid leukaemia (CML) patients on tyrosine kinase inhibitors (TKIs) show adequate antibody responses to SARS-CoV-2 vaccination, but T-cell responses remain unclear. This study investigates the overall immune responses in these patients after vaccination. Methods: In thi...

Full description

Bibliographic Details

Main Authors:	Cheong, Chin Sum, Diana Ng, Leh Ching, Yap, Siew Hwei, Reena, Rajasuriar, Normala, Arshad, Nurul Syuhada, Zulhaimi, Kong, Boon Hong, Sam, I-Ching, Bee, Ping Chong, Jesinda Pauline, Kerishnan, Gan, Gin Gin
Format:	Article
Language:	en
Published:	Academy of Medicine, Singapore. 2026
Subjects:	R Medicine (General) RC Internal medicine
Online Access:	http://ir.unimas.my/id/eprint/51841/1/V55N4-AAMS-2025-368-Online-First.pdf http://ir.unimas.my/id/eprint/51841/ https://annals.edu.sg/immune-response-sars-cov-2-vaccination-cml-patients-tki/ https://doi.org/10.47102/annals-acadmedsg.2025368
Tags:	Add Tag No Tags, Be the first to tag this record!